pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Small Molecule · news · pharmadog
← back to Small Molecule
News · Small Molecule
466
stories
19d
Novo notches up to $1.4B pact with Orbis to develop oral macrocycle cardiometabolic drugs
biospace
19d
Rare EGFR mutation increases lung cancer risk 62 times in never smokers
fiercebiotech
19d
Trending: Top biopharma disciplines with jobs live now
biospace
19d
SK pens $315M pact with fellow South Korean company for Parkinson’s prospect
fiercebiotech
20d
'Still a bull': Novo's CEO on honoring heritage and planning for the future amid corporate rebrand
fiercebiotech
20d
Sling banks $123M for an experimental thyroid eye disease pill
biopharma dive
20d
Novartis halts TREM2 targeting ALS program in 4th trial stumble in a month
biospace
20d
Skyhawk racks up more support for Huntington’s drug
biopharma dive
20d
Sling catches $123M series C for thyroid eye disease pill
biospace
20d
FDA hears input on psychedelics, PDUFA, lung cancer’s next-gen therapies boost survival
biospace
20d
Novo explores macrocycles’ potential in $1.4B cardiometabolic pact with Danish biotech
fiercebiotech
21d
Sling reels in $123M series C to fund oral Tepezza rival through phase 3 trial
fiercebiotech
21d
WCLC ‘26: A new ‘ADC era,’ China questions and AstraZeneca’s spotlight
biopharma dive
21d
Stakeholders urge FDA to define data, treatment standards as psychedelic drugs near market
biospace
21d
Despite 3 patient deaths, Cullinan-Taiho plan FDA filing for lung cancer pill on survival benefit
biospace
21d
Contineum, J&J's drug fails in mid-stage depression trial
endpoints
21d
Opinion: 3 lessons from the tobacco settlement on how states should use money from Meta
stat
21d
Novo walks away from $285M pact to develop monthly GLP-1 obesity drug with Ascendis
fiercebiotech
22d
AstraZeneca’s newly approved pill fails frontline breast cancer study
biopharma dive
22d
Definium moves toward FDA submission for LSD drug in anxiety after ‘another clear win’
biospace
22d
Novo drops ‘Nordisk’ moniker, turns bull toward future in corporate rebrand
biospace
22d
Scholar Rock SMA drug approved by FDA
biopharma dive
22d
AstraZeneca’s newly approved cancer pill fails late-stage study, blocking path to bigger market
biospace
22d
Pennsylvania records third measles-related death amid outbreak
stat
22d
Definium says its LSD drug notched another Phase 3 win in anxiety disorder
endpoints
22d
Corbus posts phase 1 obesity data for drug mechanism that defeated Novo, Sanofi
fiercebiotech
22d
Cyclic peptides open new drug frontiers, if manufacturing can keep up
biospace
22d
Psychedelic therapies ride wave of public favor into FDA hearing
biospace
24d
STAT+: Breast cancer pill from AstraZeneca misses mark in pivotal trial
stat
25d
Definium LSD drug goes 3 for 3 with another pivotal anxiety trial win
fiercebiotech
← prev
page 3 of 16
next →
